Global Diquafosol Market Size, Share and Trends Analysis Report, By Disease (Dry Eyes and Others), By End User (Hospital, Clinic, and Others), Forecast (2022-2028)

The diquafosol market is anticipated to grow at a significant CAGR 6% during the forecast period (2022-2028). Diquafosol is a solution that is prescribed for the treatment of dry eyes. Diquafosol ophthalmic solution promotes tear fluid and mucin secretion in the case of dryness in the eyes. Dry eye is a disease of the ocular surface in which tear film in the eyes is lost. In this disease, certain symptoms are seen such as tear film instability and hyperosmolarity. Hyperosmolarity is a condition in which salt and glucose concentrations in the blood increases. In this condition, water from certain organs of the body starts to decrease. Ocular surface inflammation and neurosensory abnormalities are seen in dry eyes in many cases. In dry eyes, tear in the eye are responsible for smooth eye functions and immediate eye response starts to decrease. Abnormal function of lipid is also seen. At present, certain therapies which are prescribed in the treatment of dry eyes are tear supplementation, the use of anti-inflammatory agents, etc. Retention and stimulation of tears are also prescribed in certain cases. The use of Sodium hyaluronate in a topical form has shown positive results in dry eye disease.

Diquas is prescribed for the treatment of dry eye disease. This drug has diquafosol as an active ingredient. It is found effective in keratoconjunctival epithelium disorders in which lacrimal fluid abnormality is usually observed. TFOS is a non-profit organization that facilitates ophthalmological research. According to TFOS, the prevalence rate of dry eye disease is 5-50% in the world.

The Global Diquafosol Market is segmented by disease and by end-user. Based on disease, the market is sub-segmented into dry eyes and others. Based on end-user, the market is sub-segmented into hospitals, clinics, and others.

The global diquafosol market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). Among these, Asia Pacific is anticipated to drive the market during the forecast period. A major reason for the growth in this region is the consistent change in lifestyle which is due to the information technology development and its implication.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Disease
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Alcon Vision LLC, Inspire Pharmaceuticals, Inc., Meiji Holdings Co., Ltd, Santen Pharmaceutical Co., Ltd.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Diquafosol  Market Report By Segment

By Disease

• Dry Eyes
• Others

By End-User

• Hospital
• Clinic
• Others